ADC Therapeutics(ADCT) - 2025 Q1 - Earnings Call Transcript

ADC Therapeutics (ADCT) Q1 2025 Earnings Call May 14, 2025 08:30 AM ET Company Participants Marcy Graham - Investor Relations & Corporate Affairs OfficerAmeet Mallik - CEOMohamed Zaki - Chief Medical OfficerJose Carmona - Chief Financial OfficerSudan Loganathan - Managing Director Conference Call Participants None - AnalystEric Schmidt - Biotechnology AnalystGregory Renza - Senior Biotechnology Analyst Operator morning, ladies and gentlemen, and welcome to ADC Therapeutics First Quarter twenty twenty five E ...